Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia

Schizophrenia Research

Volumn 148, Issue 1-3, 2013, Pages 130-137

  Severance, Emily G ^a   Gressitt, Kristin L ^a   Stallings, Cassie R ^b   Origoni, Andrea E ^b   Khushalani, Sunil ^b   Leweke, F Markus ^c,d   Dickerson, Faith B ^b   Yolken, Robert H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHEPPARD PRATT HEALTH SYSTEM   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Diet; Gut; Macrophage; Mental illness; Metabolic syndrome; Microbiome; Psychosis

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; CD14 ANTIGEN; GLUTEN ANTIBODY; LIPOPOLYSACCHARIDE BINDING PROTEIN; NEUROLEPTIC AGENT; PROTEIN ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL TRANSLOCATION; BIPOLAR DISORDER; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GERMANY; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; UNITED STATES;

BMI; BODY MASS INDEX; C-REACTIVE PROTEIN; CRP; DIET; GASTROINTESTINAL; GI; GUT; LBP; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LPS; MACROPHAGE; MENTAL ILLNESS; METABOLIC SYNDROME; MICROBIOME; PSYCHOSIS; SCD14; SOLUBLE CD14; TISSUE TRANSGLUTAMINASE; TTG;

ACUTE-PHASE PROTEINS; ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD14; AUTOANTIBODIES; BIPOLAR DISORDER; BODY MASS INDEX; C-REACTIVE PROTEIN; CARRIER PROTEINS; COHORT STUDIES; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; REGRESSION ANALYSIS; SCHIZOPHRENIA;

EID: 84881023923     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.05.018     Document Type: Article

References (69)

1. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96(9):939-949.
2. Beumer W., Drexhage R.C., De Wit H., Versnel M.A., Drexhage H.A., Cohen D. Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology 2012, 37(12):1901-1911.
3. Beumer W., Gibney S.M., Drexhage R.C., Pont-Lezica L., Doorduin J., Klein H.C., Steiner J., Connor T.J., Harkin A., Versnel M.A., Drexhage H.A. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J. Leukoc. Biol. 2012, 92(5):959-975.
4. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12(12):1365-1371.
5. Cascella N.G., Kryszak D., Bhatti B., Gregory P., Kelly D.L., Mc Evoy J.P., Fasano A., Eaton W.W. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr. Bull. 2011, 37(1):94-100.
6. Cinova J., Palova-Jelinkova L., Smythies L.E., Cerna M., Pecharova B., Dvorak M., Fruhauf P., Tlaskalova-Hogenova H., Smith P.D., Tuckova L. Gliadin peptides activate blood monocytes from patients with celiac disease. J. Clin. Immunol. 2007, 27(2):201-209.
7. Clemente M.G., De Virgiliis S., Kang J.S., Macatagney R., Musu M.P., Di Pierro M.R., Drago S., Congia M., Fasano A. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 2003, 52(2):218-223.
8. Crump C., Winkleby M.A., Sundquist K., Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am. J. Psychiatry 2013, 170(3):324-333.
9. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Leister F., Yang S., Krivogorsky B., Alaedini A., Yolken R. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol. Psychiatry 2010, 68(1):100-104.
10. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Alaedini A., Yolken R. Markers of gluten sensitivity and celiac disease in bipolar disorder. Bipolar Disord. 2011, 13(1):52-58.
11. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Yolken R. Markers of gluten sensitivity in acute mania: a longitudinal study. Psychiatry Res. 2012, 196(1):68-71.
12. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Yang S., Yolken R. C-reactive protein is elevated in schizophrenia. Schizophr. Res. 2013, 143(1):198-202.
13. Dohan F.C. Wartime changes in hospital admissions for schizophrenia. A comparison of admission for schizophrenia and other psychoses in six countries during World War II. Acta Psychiatr. Scand. 1966, 42(1):1-23.
14. Dohan F.C. Coeliac disease and schizophrenia. Lancet 1970, 1(7652):897-898.
15. Dohan F.C. Celiac disease and schizophrenia. N. Engl. J. Med. 1980, 302(22):1262.
16. Drexhage R.C., Knijff E.M., Padmos R.C., Heul-Nieuwenhuijzen L., Beumer W., Versnel M.A., Drexhage H.A. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev. Neurother. 2010, 10(1):59-76.
17. Drexhage R.C., Weigelt K., van Beveren N., Cohen D., Versnel M.A., Nolen W.A., Drexhage H.A. Immune and neuroimmune alterations in mood disorders and schizophrenia. Int. Rev. Neurobiol. 2011, 101:169-201.
18. DSM-IV Diagnostic and Statistical Manual of Mental Disorders: DSM-IV 1994, American Psychiatric Association, Washington, DC. 4th ed.
19. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.Y., Agerbo E., Mortensen P.B. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 2006, 163(3):521-528.
20. Eaton W.W., Pedersen M.G., Nielsen P.R., Mortensen P.B. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 2010, 12(6):638-646.
21. Fillman S.G., Cloonan N., Catts V.S., Miller L.C., Wong J., McCrossin T., Cairns M., Weickert C.S. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol. Psychiatry 2013, 18(2):206-214.
22. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Non-patient Edition (SCID I/NP) 1998, Biometrics Research, New York State Psychiatric Institute, New York.
23. Garcia-Manzanares A., Lucendo A.J., Gonzalez-Castillo S., Moreno-Fernandez J. Resolution of metabolic syndrome after following a gluten free diet in an adult woman diagnosed with celiac disease. World J. Gastrointest. Pathophysiol. 2011, 2(3):49-52.
24. Gibney S.M., Drexhage H.A. Evidence for a dysregulated immune system in the etiology of psychiatric disorders. J. Neuroimmune Pharmacol. 2013, (Epub ahead of print).
25. Gonzalez-Quintela A., Alonso M., Campos J., Vizcaino L., Loidi L., Gude F. Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 2013, 8(1):e54600.
26. Graff H., Handford A. Celiac syndrome in the case histories of five schizophrenics. Psychiatr. Q. 1961, 35:306-313.
27. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29:415-445.
28. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352(16):1685-1695.
29. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 2005, 150(6):1115-1121.
30. Heumann D., Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin. Chim. Acta 2002, 323(1-2):59-72.
31. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444(7121):860-867.
32. Jackson J., Eaton W., Cascella N., Fasano A., Warfel D., Feldman S., Richardson C., Vyas G., Linthicum J., Santora D., Warren K.R., Carpenter W.T., Kelly D.L. A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies. Schizophr. Res. 2012, 140(1-3):262-263.
33. Jackson J.R., Eaton W.W., Cascella N.G., Fasano A., Kelly D.L. Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr. Q. 2012, 83(1):91-102.
34. Jelinkova L., Tuckova L., Cinova J., Flegelova Z., Tlaskalova-Hogenova H. Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB. FEBS Lett. 2004, 571(1-3):81-85.
35. Kilbourne A.M., Morden N.E., Austin K., Ilgen M., McCarthy J.F., Dalack G., Blow F.C. Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen. Hosp. Psychiatry 2009, 31(6):555-563.
36. Kitchens R.L., Thompson P.A. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J. Endotoxin Res. 2005, 11(4):225-229.
37. Lammers K.M., Lu R., Brownley J., Lu B., Gerard C., Thomas K., Rallabhandi P., Shea-Donohue T., Tamiz A., Alkan S., Netzel-Arnett S., Antalis T., Vogel S.N., Fasano A. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008, 135(1):194-204. (e193).
38. Laursen T.M., Munk-Olsen T., Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr. Opin. Psychiatry 2012, 25(2):83-88.
39. Leonard B.E., Schwarz M., Myint A.M. The metabolic syndrome in schizophrenia: is inflammation a contributing cause?. J. Psychopharmacol. 2012, 26(5 Suppl.):33-41.
40. Leweke F.M., Gerth C.W., Koethe D., Klosterkotter J., Ruslanova I., Krivogorsky B., Torrey E.F., Yolken R.H. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2004, 254(1):4-8.
41. Maes M., Kubera M., Leunis J.C. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol. Lett. 2008, 29(1):117-124.
42. Maes M., Kubera M., Leunis J.C., Berk M. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J. Affect. Disord. 2012, 141(1):55-62.
43. Maes M., Kubera M., Leunis J.C., Berk M., Geffard M., Bosmans E. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr. Scand. 2013, 127(5):344-354.
44. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, 70(7):663-671.
45. Miller B.J., Mellor A., Buckley P. Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses. Brain Behav. Immun. 2012, (Epub ahead of print). 10.1016/j.bbi.2012.08.016.
46. Miyake K. Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol. 2004, 12(4):186-192.
47. Muller N., Myint A.M., Schwarz M.J. Inflammation in schizophrenia. Adv. Protein Chem. Struct. Biol. 2012, 88:49-68.
48. Muller N., Wagner J.K., Krause D., Weidinger E., Wildenauer A., Obermeier M., Dehning S., Gruber R., Schwarz M.J. Impaired monocyte activation in schizophrenia. Psychiatry Res. 2012, 198(3):341-346.
49. Niebuhr D.W., Li Y., Cowan D.N., Weber N.S., Fisher J.A., Ford G.M., Yolken R. Association between bovine casein antibody and new onset schizophrenia among US military personnel. Schizophr. Res. 2011, 128(1-3):51-55.
50. Padmos R.C., Van Baal G.C., Vonk R., Wijkhuijs A.J., Kahn R.S., Nolen W.A., Drexhage H.A. Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study. Arch. Gen. Psychiatry 2009, 66(9):957-965.
51. Reichelt K.L., Knivsberg A.M. The possibility and probability of a gut-to-brain connection in autism. Ann. Clin. Psychiatry 2009, 21(4):205-211.
52. Romero-Sanchez M., Gonzalez-Serna A., Pacheco Y.M., Ferrando-Martinez S., Machmach K., Garcia-Garcia M., Alvarez-Rios A.I., Vidal F., Leal M., Ruiz-Mateos E. Different biological significance of sCD14 and LPS in HIV-infection: importance of the immunovirology stage and association with HIV-disease progression markers. J. Infect. 2012, 65(5):431-438.
53. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry 2007, 64(10):1123-1131.
54. Samaroo D., Dickerson F., Kasarda D.D., Green P.H., Briani C., Yolken R.H., Alaedini A. Novel immune response to gluten in individuals with schizophrenia. Schizophr. Res. 2010, 118(1-3):248-255.
55. Sandler N.G., Douek D.C. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat. Rev. Microbiol. 2012, 10(9):655-666.
56. Severance E.G., Dickerson F.B., Halling M., Krivogorsky B., Haile L., Yang S., Stallings C.R., Origoni A.E., Bossis I., Xiao J., Dupont D., Haasnoot W., Yolken R.H. Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia. Schizophr. Res. 2010, 118(1-3):240-247.
57. Severance E.G., Dupont D., Dickerson F.B., Stallings C.R., Origoni A.E., Krivogorsky B., Yang S., Haasnoot W., Yolken R.H. Immune activation by casein dietary antigens in bipolar disorder. Bipolar Disord. 2010, 12(8):834-842.
58. Severance E.G., Alaedini A., Yang S., Halling M., Gressitt K.L., Stallings C.R., Origoni A.E., Vaughan C., Khushalani S., Leweke F.M., Dickerson F.B., Yolken R.H. Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr. Res. 2012, 138(1):48-53.
59. Severance E.G., Gressitt K.L., Halling M., Stallings C.R., Origoni A.E., Vaughan C., Khushalani S., Alaedini A., Dupont D., Dickerson F.B., Yolken R.H. Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. Neurobiol. Dis. 2012, 48(3):447-453.
60. Severance E.G., Kannan G., Gressitt K.L., Xiao J., Alaedini A., Pletnikov M.V., Yolken R.H. Anti-gluten immune response following Toxoplasma gondii infection in mice. PLoS One 2012, 7(11):e50991.
61. Soares F.L., de Oliveira Matoso R., Teixeira L.G., Menezes Z., Pereira S.S., Alves A.C., Batista N.V., de Faria A.M., Cara D.C., Ferreira A.V., Alvarez-Leite J.I. Gluten-free diet reduces adiposity, inflammation and insulin resistance associated with the induction of PPAR-alpha and PPAR-gamma expression. J. Nutr. Biochem. 2013, 24(6):1105-1111.
62. Stehle J.R., Leng X., Kitzman D.W., Nicklas B.J., Kritchevsky S.B., High K.P. Lipopolysaccharide-binding protein, a surrogate marker of microbial translocation, is associated with physical function in healthy older adults. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67(11):1212-1218.
63. Steiner J., Bernstein H.G., Schiltz K., Muller U.J., Westphal S., Drexhage H.A., Bogerts B. Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, (Epub ahead of print). 10.1016/j.pnpbp.2012.09.016.
64. Sun L., Yu Z., Ye X., Zou S., Li H., Yu D., Wu H., Chen Y., Dore J., Clement K., Hu F.B., Lin X. A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 2010, 33(9):1925-1932.
65. Suvisaari J., Partti K., Perala J., Viertio S., Saarni S.E., Lonnqvist J., Saarni S.I., Harkanen T. Mortality and its determinants in people with psychotic disorder. Psychosom. Med. 2013, 75(1):60-67.
66. Thomas K.E., Sapone A., Fasano A., Vogel S.N. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in celiac disease. J. Immunol. 2006, 176(4):2512-2521.
67. Tlaskalova-Hogenova H., Tuckova L., Stepankova R., Hudcovic T., Palova-Jelinkova L., Kozakova H., Rossmann P., Sanchez D., Cinova J., Hrncir T., Kverka M., Frolova L., Uhlig H., Powrie F., Bland P. Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Ann. N. Y. Acad. Sci. 2005, 1051:787-798.
68. Whiteley P., Haracopos D., Knivsberg A.M., Reichelt K.L., Parlar S., Jacobsen J., Seim A., Pedersen L., Schondel M., Shattock P. The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr. Neurosci. 2010, 13(2):87-100.
69. Whiteley P., Shattock P., Knivsberg A.M., Seim A., Reichelt K.L., Todd L., Carr K., Hooper M. Gluten- and casein-free dietary intervention for autism spectrum conditions. Front. Hum. Neurosci. 2012, 6:344.